TipRanks on MSN1d
GSK Executives Involved in Share Vesting and Sales
GSK announced several transactions involving the vesting and sale of ordinary shares under its Performance Share Plan and Deferred Investment Award Programme. The transactions involve key executives, ...
Annual core operating profit increases for British pharma GSK
Annual core operating profit increased in 2024 for British pharmaceutical company GSK compared to 2023, the company reported ...
J.P. Morgan Sticks to Its Sell Rating for GlaxoSmithKline (GSK)
J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.40.
UBS Reaffirms Their Hold Rating on GlaxoSmithKline (GSK)
UBS analyst Jo Walton maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of p1,580.00. The ...
The Independent16d
Cancer vaccine being created by UK scientists could stop disease up to 20 years early
Pharmaceutical giant GSK and the University of Oxford have teamed up to make a vaccine that targets cells at the pre-cancerous stage. The university has world-leading expertise in the study of pre ...
Gulf Business21d
Haleon’s Charles Leslie shares emerging trends in consumer healthcare
In an interview with Gulf Business, Charles Leslie, global business lead for the Pain Portfolio & Systemics at Haleon, outlines key consumer health trends reshaping the healthcare sector ...
Indiatimes21d
HUL to acquire direct-to-consumer brand Minimalist for nearly Rs 3,000 crore
ETtech HUL-Minimalist acquisition: Mohit and Rahul Yadav, cofounders, Minimalist Hindustan Unilever Limited (HUL) said it will acquire a 90.5% stake in direct-to-consumer beauty brand Minimalist for ...
NBC 7 San Diego22d
Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last?
A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight ... a wave of smaller deals from GSK, Eli Lilly and lesser known ...
FiercePharma22d
Sanofi's consumer health arm Opella secures FDA green light to pursue OTC Cialis study
After hitting a regulatory roadblock in 2022, Sanofi’s consumer healthcare business Opella has secured the FDA’s blessing to move forward with its ambition to convert its erectile dysfunction ...
The Motley Fool UK22d
Preparing for profit: 3 ways investors could thrive in a stock market crash
They typically operate in essential industries such as utilities, healthcare and consumer staples. As one of the UK’s leading pharmaceutical companies, GSK has a solid portfolio and extensive ...
Indiatimes22d
Reliance Consumer Products set to buy SIL's brands to spice up play; plans to compete with HUL, Cremica & Tata
Reliance Consumer Products (RCPL) is set to acquire SIL, a packaged foods brand known for products like cooking pastes, jams, and sauces. The acquisition will enable RCPL to expand its national ...
Bank of Canada23d
Canadian Survey of Consumer Expectations—Fourth Quarter of 2024
This contributed to improved consumer sentiment. Fewer consumers reported that they are spending less or plan to reduce their spending; and, for the first time since 2021, consumers said they expect ...